Sana Biotechnology, Inc. (SANA) Misses Q2 EPS by 19c
Tweet
Share
E-mailGet Alerts SANA Hot Sheet
Join SI Premium – FREE
Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q2 EPS of ($0.39), $0.19 worse than the analyst estimate of ($0.20).
For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders
- Kimbell Royalty closes $221.2M mineral rights acquisition
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
